Adagio Medical Holdings Q4 EPS $(0.21) Beats $(0.31) Estimate

Adagio Medical Holdings (NASDAQ: ADGM) reported a Q4 EPS of $(0.21), surpassing the analyst consensus estimate of $(0.31) by 32.26%. This marks a significant improvement from the same period last year, where the company reported losses of $(3.68) per share, reflecting a 94.29% decrease in losses.